1. HBW Insight
  2. >>Ingredients & Safety

J&J Starts First Baby Powder Recall Linked To Asbestos Finding

 
• By Malcolm Spicer

Recall announcement doesn't mention litigation J&JU faces in multiple states alleging use of Johnson's Baby Powder causes cancer due from talc in formulation. But firm's sensitivity to consumer complaints or adverse event reports linked to brand is clear with talc-related litigation as backdrop.

Product Recall - Image

A long-simmering potential problem with talc has prompted Johnson & Johnson's first recall of a baby powder product due to the presence of sub-trace levels of chrysotile asbestos contamination.

Separately, recent updates to the Food and Drug Administration's recalls database include a second recall of cosmetics in 2019 by...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Ingredients & Safety

AESGP Annual Meeting: Harmonizing EU VMS Max Levels Could Cost Sector Over €200m

 
• By David Ridley

Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.

EU Pharma Reform: Council Proposes Rx Exemption For Topical Antimicrobials

 
• By David Ridley

The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”

Review Suggests Advantage Of Bayer’s Iberogast Advance For Digestive Disorders

 
• By David Ridley

Bayer's Iberogast Advance's combination of six herbal ingredients may produce a synergistic effect that acts on multiple underlying issues contributing to digestive disorders like functional dyspepsia (FD) and irritable bowel syndrome (IBS), a recently published study suggests.

Allergy Ingredient Itch Warning, ACNU Final Rule Scratch Extent Of FDA Authority For Label Changes

 
• By Malcolm Spicer

Effective date for ACNU OTC switch final rule and finding of severe itching from long-term use of common allergy ingredients are bookends for limits of FDA’s authority for product label changes.

More from HBW Insight

SkinBioTherapeutics Raises Funds For Supplement Development And Launch

 
• By Tom Gallen

UK-based firm will use the capital to launch its AxisBiotix skin health supplements in Superdrug stores and to develop new product formats.

Wellness Firms Targeting GLP-1 Patients’ Dietary Needs Keep Option To Provide Access To Oral Rx

Health and wellness brands and retail chains providing access to prescriptions for compounded GLP-1 drugs, most also offering supplements curated to help meet dietary needs of GLP-1 patients, are offering formulations in oral form as well as injection.

Leonard Lauder, ‘Visionary’ Who Grew Estee Lauder Into Global Beauty Powerhouse, Passes At 92

 
• By Eileen Francis

The Estee Lauder Companies’ Chairman Emeritus Leonard Lauder, who is credited with growing his family’s firm into a global beauty powerhouse over six decades through the launch and acquisition of iconic brands and expansion into Europe, Asia and the Middle East, passed away 14 June.